| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net loss | |||||||||
-16,490 | 20,738 | 22,811 | 350 | -12,602 | -10,479 | -6,072 | 50,985 | - | - |
Net Loss | |||||||||
- | - | - | - | - | - | - | - | -17,980 | -47,809 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Loss on sale of subsidiary | |||||||||
- | - | - | - | - | -1,626 | 0 | 0 | - | -9,337 |
Return on investment | |||||||||
- | - | - | - | 1,271 | 0 | - | - | - | - |
Depreciation and amortization | |||||||||
2,038 | 1,800 | 815 | 63 | 50 | 14 | 241 | 0 | - | - |
Non-cash lease expense | |||||||||
500 | - | - | - | - | - | - | - | - | - |
Accretion of intangible assets | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Loss on disposal of assets | |||||||||
- | - | - | - | -34 | 0 | - | - | - | - |
Change in fair value of warrant liability | |||||||||
0 | 3,445 | -2,217 | 0 | 0 | - | - | - | - | - |
Deferred income taxes | |||||||||
-4,456 | 2,712 | -6,201 | 0 | 0 | - | - | - | - | - |
Stock-based compensation | |||||||||
968 | 1,593 | 843 | 872 | 766 | 1,448 | - | - | 1,557 | - |
Net effect of exchange rate changes on cash | |||||||||
- | - | - | - | - | - | - | - | 41 | -0 |
Net Increase Cash and Cash Equivalents | |||||||||
- | - | - | 7,577 | -11,404 | -7,075 | -66,965 | 63,735 | -2,785 | -7,668 |
Supplemental Disclosures of Cash Flow Information: | |||||||||
Cash paid for income taxes | |||||||||
0 | 10,700 | 30 | 0 | 7 | 25,331 | - | - | - | - |
Income Taxes | |||||||||
- | - | - | - | - | - | 25,331 | - | - | - |
Non-cash investing and financing activities: | |||||||||
Distribution of investment held by investee | |||||||||
- | - | - | - | 445 | 0 | 12,784 | - | - | - |
Leasehold improvements financed | |||||||||
- | - | - | - | - | - | 35 | - | - | - |
Patent purchase in exchange for payable | |||||||||
0 | 0 | 6,500 | 0 | 0 | - | - | - | - | - |
Changes in accounts receivable, adoption of ASC606 | |||||||||
-2,550 | -2,606 | 1,540 | 1,066 | - | - | - | - | - | - |
Loss from sale of investment | |||||||||
700 | 0 | 0 | - | - | - | - | - | - | - |
Amortization expense of intangible assets and other assets | |||||||||
- | - | - | - | - | - | - | - | 1,199 | 1,184 |
Depreciation and amortization of property and equipment | |||||||||
- | - | - | - | - | - | - | - | 288 | 1,435 |
Amortization of discount and premium on investments | |||||||||
-261 | 1,483 | 0 | - | - | - | - | - | 7,904 | 360 |
Stock-based compensation expense | |||||||||
- | - | - | - | - | - | 1,189 | 0 | - | - |
Shares received in settlement of litigation | |||||||||
- | - | - | - | - | - | 0 | 8,353 | - | - |
Shares received in exchange for modification of license agreement | |||||||||
- | - | - | - | - | - | 0 | 3,116 | - | - |
Tax provision contributed by Former Parent | |||||||||
- | - | - | - | - | - | -263 | 1,564 | - | - |
Deferred tax liability related to discontinued operations | |||||||||
- | - | - | - | - | -39 | -4 | 0 | - | - |
Common stock issued as compensation | |||||||||
- | - | - | - | - | - | - | - | - | -442 |
Common stock issued as payment of expenses | |||||||||
- | - | - | - | - | - | - | - | -85 | 1,501 |
Stock option compensation expense | |||||||||
- | - | - | - | - | - | - | - | 669 | 1,310 |
Gain on sale of patents | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Changes in operating assets and liabilities: | |||||||||
Provision for losses on accounts receivable | |||||||||
- | - | - | - | - | - | - | - | - | 1,112 |
Interest expense in relation to issuance of convertible debt | |||||||||
- | - | - | - | - | - | - | - | 268 | 1,368 |
Gain on change in fair value of obligations to issue shares | |||||||||
- | - | - | - | - | - | - | - | 640 | - |
Gain on settlement of debt | |||||||||
- | - | - | - | - | - | - | - | 225 | - |
Gain on debt extinguishment | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Gain on change in fair value of obligations to issue shares | |||||||||
- | - | - | - | - | - | - | - | - | 123 |
Loss on debt modification | |||||||||
- | - | - | - | - | - | - | - | -2,357 | - |
Gain on settlement of accounts payable | |||||||||
- | - | - | - | - | - | - | - | 402 | - |
Impairment of long-term assets | |||||||||
- | - | - | - | - | - | - | - | - | 15,383 |
Goodwill impairment | |||||||||
- | - | - | - | - | - | - | - | 1,186 | - |
Impairment of intangible assets | |||||||||
- | - | - | - | - | - | - | - | 3,563 | - |
Loss on abandonment of asset | |||||||||
- | - | - | - | - | - | - | - | -951 | - |
Loss on write-down of construction costs | |||||||||
- | - | - | - | - | - | - | - | 113 | - |
Gain on change in fair value of derivative liability | |||||||||
- | - | - | - | - | - | - | - | 5,823 | 1,382 |
Loss on investment in discontinued operations | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Accounts receivable | |||||||||
-2,550 | -2,606 | 1,540 | 1,066 | -2,016 | 2,003 | -152 | 0 | -296 | 221 |
Inventories | |||||||||
- | - | - | - | - | - | - | - | 147 | -322 |
Prepaid expenses and other assets | |||||||||
-6,292 | 6,029 | 152 | -34 | 535 | 13 | 82 | 3 | -197 | 14 |
Accrued income taxes | |||||||||
0 | -13 | 10 | -6 | 9 | -4 | -25,321 | 24,633 | - | - |
Lease liability | |||||||||
-485 | - | - | - | - | - | - | - | - | - |
Accounts payable | |||||||||
87 | -252 | 2,788 | - | - | - | - | - | - | - |
Other non-current assets | |||||||||
- | - | - | - | - | 0 | 23 | 0 | - | - |
Deposits and other non-current assets | |||||||||
- | - | - | - | - | - | - | - | -40 | -280 |
Accounts payable | |||||||||
- | - | - | -362 | 545 | 1,259 | -2,331 | 1,740 | -965 | 1,302 |
Accounts payable - related parties | |||||||||
-75 | 51 | 24 | 71 | -83 | 85 | -2 | 2 | - | - |
Accrued expenses | |||||||||
-134 | -909 | -529 | 1,382 | -350 | 518 | -346 | 68 | -308 | 2,705 |
Other liabilities | |||||||||
-1,093 | -1,624 | -66 | -10 | 162 | 0 | - | - | - | - |
Deferred revenue | |||||||||
- | - | - | - | - | - | - | - | 95 | - |
Net cash used in operating activities | |||||||||
-9,885 | 25,601 | 16,586 | 1,328 | -11,259 | -7,361 | -32,786 | 67,520 | -5,718 | -11,502 |
Net assets related to discontinued operations | |||||||||
- | - | - | - | - | -227 | -76 | 0 | - | - |
Net Cash Provided by discontinued operations | |||||||||
- | - | - | - | - | 1,814 | 72 | 0 | - | - |
Net cash provided by (used in) operating activities | |||||||||
- | - | - | - | - | 1,304 | -26,786 | 16,535 | - | - |
Cash flows from investing activities: | |||||||||
Proceeds from sale of Converted Organics | |||||||||
- | - | - | - | - | 675 | 0 | 0 | - | - |
Cash received in sale of discontinued operations | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Cash provided in sale of discontinued operations | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Patent costs | |||||||||
- | - | - | - | - | - | - | - | 28 | 1 |
Purchase of other assets | |||||||||
- | - | - | - | - | - | - | - | 0 | 500 |
Purchase of intangible assets | |||||||||
0 | 1,000 | 2,000 | 0 | 0 | - | - | - | - | - |
Purchases of additional investment | |||||||||
700 | 900 | 0 | 550 | 750 | 500 | 500 | 1,601 | - | - |
Proceeds from sale of investment | |||||||||
3,539 | 0 | 127 | - | - | - | - | - | - | - |
Purchase of marketable securities | |||||||||
24,562 | 11,303 | 0 | 0 | - | - | - | - | - | - |
Redemptions and maturities of marketable securities | |||||||||
18,347 | 0 | 0 | - | - | - | - | - | - | - |
Proceeds from investments | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Proceeds from investment | |||||||||
- | - | - | - | 826 | 0 | 0 | 286 | - | - |
Distribution from investment | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Release of restricted cash | |||||||||
- | - | - | - | - | - | - | - | - | -613 |
Cash acquired through merger with Converted Organics | |||||||||
- | - | - | - | - | - | 63 | 0 | - | 98 |
Proceeds of notes receivable acquired through merger with Converted Organics | |||||||||
- | - | - | - | - | - | 517 | 0 | - | - |
Purchase of property and equipment | |||||||||
446 | 0 | 0 | 9 | 275 | 21 | 111 | 0 | 1,199 | 656 |
Net cash provided by (used in) investing activities | |||||||||
-3,822 | -13,203 | -1,873 | -559 | -199 | 154 | -31 | -1,315 | -1,228 | -445 |
Cash flows from financing activities | |||||||||
Proceeds from the sale of Series A-1 Preferred shares, net of issuance costs | |||||||||
0 | 0 | 14,375 | - | - | - | - | - | - | - |
Redemption of Preferred shares | |||||||||
0 | 19,890 | 13,778 | 2,793 | 0 | - | - | - | - | - |
Repayment of capital lease obligations | |||||||||
- | - | - | - | - | - | - | - | - | 11 |
Proceeds from Common share offering, net of issuance costs | |||||||||
0 | 0 | 11,952 | 0 | 0 | - | - | - | - | 2,366 |
Repayment of loan from former parent | |||||||||
- | - | - | - | - | - | 33,943 | 2,470 | 125 | 1,542 |
Repurchase of Finjan Holdings shares | |||||||||
0 | 2,023 | 0 | 0 | - | - | 205 | 0 | - | - |
Repayments to related party | |||||||||
- | - | - | - | - | - | - | - | - | 10 |
Proceeds from exercise of stock options | |||||||||
0 | 357 | 229 | 111 | 54 | 132 | 0 | 0 | - | 34 |
Net proceeds from short-term notes | |||||||||
- | - | - | - | - | - | - | - | -4,500 | 3,444 |
Deferred financing costs for short-term notes | |||||||||
- | - | - | - | - | - | - | - | 255 | - |
Net cash provided by financing activities | |||||||||
0 | -21,556 | 12,778 | 6,808 | 54 | 132 | -34,148 | -2,470 | 4,120 | 4,280 |
Net increase (decrease) in cash and cash equivalents | |||||||||
-13,707 | -9,158 | 27,491 | - | - | - | - | - | - | - |
Interest | |||||||||
- | - | - | - | - | - | - | - | 28 | 952 |
Common stock issued to settle convertible notes obligations | |||||||||
- | - | - | - | - | - | - | - | 8,174 | - |
Fair value of derivatives issued in conjunction with debt and equity financing | |||||||||
- | - | - | - | - | - | - | - | 4,667 | 6,882 |
Discount on convertible note issued in connection with financings | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Fair value of contingent consideration in relation to acquisition | |||||||||
- | - | - | - | - | - | - | - | - | 773 |
Issuance of common stock in conjunction with the acquisitions | |||||||||
- | - | - | - | - | - | - | - | - | 6,131 |
Discount on convertible note issued in connection with financings | |||||||||
- | - | - | - | - | - | - | - | - | 3,750 |
Exchange of investment to reduce convertible notes obligations | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Common stock issued as settlement of discontinued operations obligations | |||||||||
- | - | - | - | - | - | - | - | 1,344 | - |
Common stock issued in connection with conversion of preferred stock | |||||||||
- | - | - | - | - | - | - | - | 4,219 | - |
Reclassification of warrant liability to equity | |||||||||
0 | 4,541 | 0 | 0 | - | - | - | - | - | 413 |
Common stock issued as settlement of discontinued operations obligations | |||||||||
- | - | - | - | - | - | - | - | - | 11,754 |
Preferred stock issued in satisfaction of bonds payable | |||||||||
- | - | - | - | - | - | - | - | - | 17,500 |
Series A Preferred Stock | |||||||||
Accretion of Preferred Stock | |||||||||
0 | 0 | 292 | 6,789 | - | - | - | - | - | - |
Proceeds from the sale of Series Preferred shares, net of issuance costs | |||||||||
- | - | - | 9,490 | - | - | - | - | - | - |
Series A-1 Preferred Stock | |||||||||
Accretion of Preferred Stock | |||||||||
0 | 925 | 4,590 | 0 | - | - | - | - | - | - |
Proceeds from the sale of Series Preferred shares, net of issuance costs | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Accounting Standards Update 2014-09 | |||||||||
Changes in accounts receivable, adoption of ASC606 | |||||||||
0 | 2,550 | 0 | 0 | - | - | - | - | - | - |
Changes in deferred tax, adoption of ASC606 | |||||||||
0 | 678 | 0 | 0 | - | - | - | - | - | - |
Accounts receivable | |||||||||
0 | 2,550 | 0 | 0 | - | - | - | - | - | - |